Corbus Pharmaceuticals Holdings (CRBP) Earnings Analysis
Corbus Pharmaceuticals Holdings (CRBP) next reports earnings on 2026-08-11, consensus EPS -1.3 USD. Last quarter (2026-03-09) it beat with EPS -1.25 USD vs -1.78 USD est (+29.8%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -1.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRBP next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -1.3 USD |
| Revenue estimate | n/a |
CRBP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-09 | -1.25 USD | -1.78 USD | +29.8% | Beat |
| 2025-03-11 | -0.78 USD | -1.02 USD | +23.5% | Beat |
| 2024-11-07 | -1.15 USD | -0.99 USD | -16.2% | Miss |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
CRBP valuation and analyst view
| Trailing P/E | -1.34 |
|---|---|
| Trailing EPS | -6.34732 USD |
| Price / book | 0.93 |
| Dividend yield | 0.00% |
| Market cap | 0.11B |
| Analyst consensus | Buy (14 buy / 2 hold / 0 sell) |
| Avg price target | 38.5 USD |
Related research pages
Frequently asked questions
When is Corbus Pharmaceuticals Holdings (CRBP)'s next earnings date?
Corbus Pharmaceuticals Holdings is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -1.3 USD.
Did CRBP beat earnings last quarter?
In its 2026-03-09 report, CRBP posted EPS of -1.25 USD versus a -1.78 USD estimate — a beat of 29.8%.
What is CRBP's earnings track record?
Over the last 3 reported quarters with consensus data, CRBP beat estimates 2 times (67%).
What is CRBP's current P/E ratio and EPS?
CRBP trades at a trailing P/E of -1.34 on trailing EPS of -6.347320245614741 USD.
What do analysts rate CRBP?
Analyst consensus is "Buy" across 16 ratings (0 strong buy, 14 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 38.5 USD.